Priya and Michael chat with the editors of the Journal of Cardiac Failure about what constructive disruption to scientific publishing means, touching on broad inclusion, double-blind peer reviews within seven days, being a platform for critical documents that help to define the field, mentorship, and what’s on the horizon for the JCF ..read more

The newly released HF Stats℠ revealed that the incidence, prevalence, mortality and hospitalization rates of heart failure are increasing despite advances in treatment modalities, guideline recommendations, and strategies for implementation. Our hosts sat down with Dr. Biykem Bozkurt, the lead author on the 2023 HF Stats℠ annual report Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America at the HFSA Annual Scientific Meeting 2023 to discuss trends, report outcomes, and next steps.   ..read more

On this episode, we bring you interviews recorded live at the HFSA Annual Scientific Meeting in early October 2023. The episode kicks off with a discussion with HFSA President James C. Fang, MD, FHFSA (00:50), followed by chats with three Late Breaking Clinical Trial presenters [Marat Fudim, MD (07:09); MHS; Marvin Konstam, MD (12:10); and James L. Januzzi, MD, FACC, FESC (17:55)]; and finally, a highlight reel with HFSA Social Media Catalysts Anju Bhardwaj, MD and Shashank S. Sinha, MD, MSc (25:20).   ..read more

Our co-hosts interview Jacob Abraham, MD, about navigating the concepts and controversies surrounding Ambulatory PA Pressure Monitoring for heart failure patients.  ..read more

In this month's featured discussion, our co-hosts interview Jeffrey Teuteberg, MD, and Shelley Hall, MD, on the 2018 update to the UNOS allocation system for donor hearts and where the heart transplant community is moving to in the future regarding this issue ..read more

In this month's featured discussion, our co-hosts welcome Yousif Ahmad, BMBS, MRCP, PhD, and review the evidence supporting coronary revascularization in patients with ischemic heart failure ..read more

Our co-hosts interview Paul Heidenreich, MD, FHFSA a co-author of the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure about economic considerations in the management of HF. On "From Failure to Function", Priya dives into the late breaking trials from ACC.23 and Michael reviews three papers on HFpEF on HF Rounds ..read more

On part two of this episode series, hosts Michael Beasley, MD and Priya Umapathi, MD continue their discussion on the top highlights of 2022 with current HFSA president Dr. John Teerlink. The STRONG-HF clinical trial, the future of Omecamtiv Mecarbil and the METEORIC-HF trial are discussed. Priya introduces her new episode segment "From Failure to Function," which summarizes the latest heart failure research presented at meetings around the world ..read more

Hosts Michael Beasley, MD and Priya Umapathi, MD interview current and immediate past presidents John Teerlink MD, FHFSA, and Mark Drazner MD, MSc, FHFSA on the most significant events that took place in the field of heart failure in 2022 on this two-part series. Part one dives into SGLT2 inhibitors, the rapid uptitration of GDMT, and cardiac xenotransplantation. Michael also delivers HF Rounds, his new segment which features a succinct peek into interesting news from HF journals. Stay tuned for Part II coming in January ..read more

Tune in as co-authors Alanna Morris, MS, MSc, and Robert Page, PharmD, of the HFSA Position Paper The Impact of Healthcare Disparities on Patients with Heart Failure further discuss this important topic. Live Discussion originally broadcasted on the HFSA Twitter and YouTube on May 27, 2022 ..read more